ziprasidone has been researched along with Intellectual Disability in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brugnoli, R; Carlino, N; D'Andreagiovanni, M; De Giorgi, R; Del Casale, A; Giardini, M; Girardi, P; Kotzalidis, GD; Rapinesi, C; Sacco, M | 1 |
| Cohen, S; Fitzgerald, B; Khan, A; Khan, S; Okos, A | 1 |
1 trial(s) available for ziprasidone and Intellectual Disability
| Article | Year |
|---|---|
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intellectual Disability; Lipids; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Triglycerides | 2003 |
1 other study(ies) available for ziprasidone and Intellectual Disability
| Article | Year |
|---|---|
Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
Topics: Adult; Antipsychotic Agents; Autistic Disorder; Comorbidity; Gilbert Disease; Humans; Intellectual Disability; Male; Piperazines; Psychotic Disorders; Risperidone; Thiazoles | 2016 |